Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 58)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
20-Nov-09 New Constructs, LLC N/A GENZ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: GENZYME -- GENZ 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GENZYME CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AMGN , BIIB , GENZ , GILD -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 13)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
18-Nov-09 Thomson StreetEvents N/A GENZ - Event Transcript of Genzyme Corporation conference call, Nov. 17, 2009 / 12:00pm ET 24 $75 View Abstract
18-Nov-09 Thomson StreetEvents N/A GENZ - Event Transcript of Genzyme Corporation conference call, Nov. 18, 2009 / 10:30am ET 8 $75 View Abstract
17-Nov-09 Thomson StreetEvents N/A GENZ - Event Brief of Genzyme Corporation conference call, Nov. 16, 2009 / 12:00pm ET 24 $75 View Abstract
17-Nov-09 Thomson StreetEvents N/A GENZ - Event Transcript of Genzyme Corporation conference call, Nov. 16, 2009 / 12:00pm ET 24 $75 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 20 $50 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino BMRN Smashes Q3 EPS Expectations 6 $25 View Abstract
22-Oct-09 Thomson StreetEvents N/A GENZ - Event Brief of Genzyme Corporation conference call, Oct. 21, 2009 / 11:00am ET 30 $75 View Abstract
22-Oct-09 Thomson StreetEvents N/A GENZ - Event Transcript of Genzyme Corporation conference call, Oct. 21, 2009 / 11:00am ET 28 $75 View Abstract
22-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA Awaiting Regulatory and Manufacturing Clarity in 4Q09 8 $25 View Abstract
21-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA First Take: 3Q09 EPS is Light, but Manufacturing Comments are Key 5 $10 View Abstract
Next 3

Independent Reports (Showing 1 to 10 of 45)

Release
Date Contributor Author Title Pages Price More Info
30-Nov-09 Freedonia Group Inc, The The Freedonia Group Freedonia Focus on Cancer Therapies 23 $500 View Abstract
20-Nov-09 New Constructs, LLC N/A GENZ: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Stock Traders Daily Thomas H. Kee Jr. S&P Valuation Analysis 13 $50 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: GENZYME -- GENZ 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GENZYME CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AMGN , BIIB , GENZ , GILD -- DRUGS 3 $4 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.